Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Psychosom Res. 2019 Jan 7;118:18–26. doi: 10.1016/j.jpsychores.2019.01.002

Figure 2. Symptoms of Anxiety and Depression and Use of Anxiolytic-Hypnotics and Antidepressants by GOLD Stage.

Figure 2.

Anxiety symptoms, depressive symptoms, anxiolytic-hypnotic use, antidepressant use, and unmedicated symptoms across GOLD severity stages using ANOVA followed by post-hoc group-by-group comparisons. *p<0.05; †p<0.001